CXCL9 and neoplasm: This effect was mediated through β2-adrenergic receptor signaling, which reduced C-X-C motif chemokine ligand 9 (CXCL9) secretion by tumor cells, thereby limiting CD8+ T cell infiltration into the tumor [77].